drugset / Trial / NCT01467687
Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to determine the bioequivalency of Synerx Pharma Verapamil extended release capsules.
Timeline
- Start
- 2007-07
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Verapamil | Other / unclassified | 300 mg | Oral |
Indications
No indication recorded.